Rooha Contractor

2.7k citations

26 papers · 2.3k · 1 hit paper · h-index 16

Impact in

Molecular Biology top 5%
- Cell death mechanisms and regulation
- Melanoma and MAPK Pathways
- Natural product bioactivities and synthesis
Hematology top 5%
- Acute Myeloid Leukemia Research

Papers in

Molecular Biology 17
- Melanoma and MAPK Pathways 6
- Cell death mechanisms and regulation 4
- Retinoids in leukemia and cellular processes 2
- Histone Deacetylase Inhibitors Research 2
- Epigenetics and DNA Methylation 1
- Mitochondrial Function and Pathology 1
Hematology 2
- Acute Myeloid Leukemia Research 2

Co-authors: Michael Andreeff (16 shared papers)Marina Y Konopleva (15 shared papers)Meenhard Herlyn (6 shared papers)Keiran S.M. Smalley (5 shared papers)Nikolas K. Haass (5 shared papers)Katherine L. Nathanson (3 shared papers)Ismael J. Samudio (7 shared papers)David Harris (2 shared papers)
Journals: Blood (6 papers)Cancer Research (6 papers)Leukemia (2 papers)Melanoma Research (1 paper)Annals of Hematology (1 paper)
Partner nations: United States Japan India

In The Last Decade

Rooha Contractor

26 papers receiving 2.3k citations

Rooha Contractor's Hit Papers

align trajectories log scale

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia 2006 · 901 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2006 Cancer Cell

Peers

Countries citing papers authored by Rooha Contractor

Since Specialization

Citations

This map shows the geographic impact of Rooha Contractor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rooha Contractor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rooha Contractor more than expected).

Fields of papers citing papers by Rooha Contractor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rooha Contractor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rooha Contractor. The network helps show where Rooha Contractor may publish in the future.

Co-authors

The 25 scholars most cited alongside Rooha Contractor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rooha Contractor Line = papers co-authored together Rooha Contractor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia Cancer Cell ·Marina Y Konopleva, Rooha Contractor, Twee Tsao, Ismael J. Samudio, Peter P. Ruvolo, Shinichi Kitada, Xingming Deng, Dayong Zhai Hit paper breakdown →	2006	901
2	Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax) Cancer Research ·Marina Y Konopleva, Julie C. Watt, Rooha Contractor, Twee Tsao, David Harris, Zeev E. Estrov, William G. Bornmann, Hagop M. Kantarjian	2008	230
3	The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel Clinical Cancer Research ·Nikolas K. Haass, Katrin Sproesser, Thiennga K. Nguyen, Rooha Contractor, Katherine L. Nathanson, Meenhard Herlyn, Keiran S.M. Smalley +1 other	2008	201
4	An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells Cancer Research ·Keiran S.M. Smalley, Rooha Contractor, Nikolas K. Haass, Angela N. Kulp, Gunes Ekin Atilla‐Gokcumen, Douglas S. Williams, Howard S. Bregman, Keith T. Flaherty	2007	191
5	A Novel Ring-Substituted Diindolylmethane,1,1-Bis[3′-(5-Methoxyindolyl)]-1-(p-t-Butylphenyl) Methane, Inhibits Extracellular Signal-Regulated Kinase Activation and Induces Apoptosis in Acute Myelogenous Leukemia Cancer Research ·Rooha Contractor, Ismael J. Samudio, Zeev E. Estrov, David Harris, James Andrew McCubrey, Stephen H Safe, Michael Andreeff, Marina Y Konopleva	2005	118
6	Evidence of Gender- and Tissue-Specific Promoter Methylation and the Potential for Ethinylestradiol-Induced Changes in Japanese Medaka (Oryzias Latipes) Estrogen Receptor and Aromatase Genes Journal of Toxicology and Environmental Health ·Rooha Contractor, Christy M. Foran, Shuanfang Li, Kristine L. Willett	2004	88
7	Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells Blood ·Yoko Tabe, Marina Y Konopleva, Rooha Contractor, Mark F. Munsell, Wendy D. Schober, Linhua Jin, Yuko Tsutsumi‐Ishii, Isao Nagaoka	2005	87
8	Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression Cancer Research ·Keiran S.M. Smalley, Rooha Contractor, Thiennga K. Nguyen, Min Xiao, Robin H. Edwards, Viswanathan Muthusamy, Alastair J. King, Keith T. Flaherty	2008	87
9	Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels British Journal of Cancer ·Keiran S.M. Smalley, Rooha Contractor, Nikolas K. Haass, J T Lee, Katherine L. Nathanson, Keith T. Flaherty, Meenhard Herlyn +1 other	2007	79
10	HPV16/18 Prevalence in Cervical Lesions/Cancers and p53 Genotypes in Cervical Cancer Patients from India Gynecologic Oncology ·Dhananjaya Saranath, Anita T. Tandle, Pratiksha Dedhia, Bhuvnesh Kumar Sharma, Rooha Contractor, S.K. Shrivastava, K.A. Dinshaw +1 other	2002	59
11	The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells Leukemia ·Marina Y Konopleva, Rooha Contractor, Svitlana M. Kurinna, W. Chen, Michael Andreeff, Peter P. Ruvolo	2005	59
12	A Novel Mechanism of Action of Methyl-2-cyano-3,12 Dioxoolean-1,9 Diene-28-oate: Direct Permeabilization of the Inner Mitochondrial Membrane to Inhibit Electron Transport and Induce Apoptosis Molecular Pharmacology ·Ismael J. Samudio, Marina Y Konopleva, Hélène Pelicano, Peng Huang, Olga Frolova, William G. Bornmann, Yunming Ying, Randall L. Evans	2006	52
13	Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1 Cell Death and Differentiation ·Yoko Tabe, Rooha Contractor, David Lee Gold, Peter P. Ruvolo, Susanne Radke, Yunyun Xu, Y Tsutusmi-Ishii, Shōichi Kondō	2007	50
14	Bcl2 phosphorylation and active PKC α are associated with poor survival in AML Leukemia ·Svitlana M. Kurinna, Marina Y Konopleva, Shana L. Palla, W. Chen, Steven Mitchell Kornblau, Rooha Contractor, Xingming Deng, William Stratford May	2006	37
15	PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL Cancer Biology & Therapy ·Yoko Tabe, Marina Y Konopleva, Yutaka Kondo, Rooha Contractor, Twee Tsao, Sergej Naumovich Konoplev, Yuexi Shi, Xiaoyang Ling	2007	32
16	Development of a Conditional In vivo Model to Evaluate the Efficacy of Small Molecule Inhibitors for the Treatment of Raf-Transformed Hematopoietic Cells Cancer Research ·Marina Y Konopleva, Yuexi Shi, Linda S. Steelman, John G. Shelton, Mark F. Munsell, Frank C. Marini, Teresa J. McQueen, Rooha Contractor	2005	16
17	PML-RARα and AML1–ETO translocations are rarely associated with methylation of the RARβ2 promoter Annals of Hematology ·Yoko Tabe, Marina Y Konopleva, Yutaka Kondo, Rooha Contractor, Linhua Jin, Vivian R. Ruvolo, Yuko Tsutsumi‐Ishii, Kazunori Miyake	2006	16
18	Inhibition of Bcl-2 Signaling by Small Molecule BH3 Inhibitor GX15-070 as a Novel Therapeutic Strategy in AML. Blood ·Rooha Contractor, Marina Y Konopleva, Ismael J. Samudio, Hagop M. Kantarjian, Michael Andreeff	2005	3
19	The novel MEK inhibitor AZD6244/ARRY142886 inhibits the growth of melanomas harboring the BRAFV600E mutation in vitro and in vivo Melanoma Research ·Nikolas K. Haass, Keiran S.M. Smalley, Rooha Contractor, Katrin Sproesser, Meenhard Herlyn	2006	3
20	Mechanism of apoptosis induction by chemical inhibitors of bcl-2 in acute leukemia cells Cancer Research ·Marina Y Konopleva, Rooha Contractor, Peter P. Ruvolo, Xingming Deng, Ismael J. Samudio, Yuexi Shi, Teresa J. McQueen, Ruiyu Wang	2006	2

About Rooha Contractor

Rooha Contractor is a scholar working on Molecular Biology, Hematology, Oncology, Physiology and Epidemiology, having authored 26 papers that have together received 2.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Cell death mechanisms and regulation (4 papers), Retinoids in leukemia and cellular processes (2 papers), Acute Myeloid Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cervical Cancer and HPV Research (1 paper), Epigenetics and DNA Methylation (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Molecular Biology (1.0k citations), Hematology (224 citations), Physiology (34 citations), Oncology (207 citations) and Genetics (59 citations). Rooha Contractor has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Michael Andreeff, Marina Y Konopleva, Meenhard Herlyn, Keiran S.M. Smalley, Nikolas K. Haass, Katherine L. Nathanson, Ismael J. Samudio, David Harris, Zeev E. Estrov and Keith T. Flaherty. Their work appears in journals such as Blood, Cancer Research, Leukemia, Melanoma Research and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rooha Contractor

Impact in

Papers in i

In The Last Decade

Rooha Contractor

Rooha Contractor's Hit Papers

Peers

Countries citing papers authored by Rooha Contractor

Fields of papers citing papers by Rooha Contractor

All Works

About Rooha Contractor

Explore authors with similar magnitude of impact

Papers in